Related Experiment Video
Updated: Aug 6, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
The renin-angiotensin system and vascular hypertrophy
1Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Journal of the American College of Cardiology
|October 1, 1996
Summary
Angiotensin II promotes cardiovascular cell growth, leading to conditions like myocardial hypertrophy. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers can reverse these vascular changes in hypertension.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Pharmacology
Background:
- Angiotensin II is a key hormone in cardiovascular regulation.
- It stimulates cell growth, proliferation, and matrix synthesis in the cardiovascular system.
- These effects are mediated via angiotensin II receptors (subtype AT1).
Purpose of the Study:
- To elucidate the role of angiotensin II in cardiovascular cell growth and vascular remodeling.
- To investigate the mechanisms of angiotensin II-induced cellular responses.
- To evaluate the effects of ACE inhibitors and AT1 antagonists on vascular changes in hypertension.
Main Methods:
- Review of existing literature on angiotensin II signaling pathways.
- Analysis of cellular responses in vascular smooth muscle.
- Examination of animal models of hypertension.
- Clinical data on the effects of ACE inhibitors and AT1 antagonists in human hypertension.
Main Results:
- Angiotensin II induces myocardial hypertrophy and vascular hyperplasia/hypertrophy via AT1 receptors.
- Specific signaling pathways involving protooncogenes and growth factors are activated.
- Different forms of hypertension show distinct vascular structural changes.
- ACE inhibitors and AT1 antagonists demonstrate potential to reverse vascular hypertrophy and improve arterial compliance.
Conclusions:
- Angiotensin II plays a significant role in cardiovascular structural changes associated with hypertension.
- Targeting the renin-angiotensin system with ACE inhibitors or AT1 antagonists offers therapeutic potential for vascular remodeling in hypertension.
- Further clinical trials are needed to confirm the clinical implications of these findings.
Related Concept Videos
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...